Shopping Cart
- Remove All
Your shopping cart is currently empty
β-Secretase inhibitor-STA
Catalog No. T3161Cas No. 350228-37-4
BACE-IN-1 is amyloid precursor protein beta-secretase inhibitor
β-Secretase inhibitor-STA
Catalog No. T3161Cas No. 350228-37-4
BACE-IN-1 is amyloid precursor protein beta-secretase inhibitor
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $152 | Backorder |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "β-Secretase inhibitor-STA"
Verubecestat
MK-8931
T70111286770-55-5
Verubecestat (MK-8931) (MK-8931) is an effective and specific β-secretase inhibitor and β-site APP-cleaving enzyme 1 inhibitor or BACE1 protein inhibitor.
- $34
Size
QTY
Eslicarbazepine Acetate
Zebinix, Stedesa, Exalief, BIA 2-093, Aptiom
T3285236395-14-5
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
- $32
Size
QTY
Epiberberine
T5S23616873-09-2
1. Epiberberine may be caused drug interactions based on CYP2D6 enzyme. 2. Epiberberine has anti-adipogenic effect is mediated by downregulation of the Raf/MEK1/ERK1/2 and AMPKα/Akt pathways during 3T3-L1 adipocyte differentiation. 3. Epiberberine, as the brightest FSA emitter among the alkaloids, can also serve as an efficient conformation probe for HTG DNA and discriminate the DNA G-quadruplex from the RNA counterpart.
- $31
Size
QTY
LY2886721
T60581262036-50-9
LY2886721, a BACE inhibitor, is used for the therapy of Alzheimer's Disease.
- $43
Size
QTY
Tenuifolin
T376920183-47-5
Tenuifolin has no inherent toxicity to either the transfected or wild type cells at the effective concentrations, it inhibits amyloid-β secretion in vitro.
- $41
Size
QTY
Aloeresin D
T8179105317-67-7
Aloeresin D, a natural chromone glycoside, inhibits β-Secretase (BACE1) activity (IC50: 39 μM).
- $56
Size
QTY
LX2343
T4398333745-53-2
LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM and acts as a non-ATP competitive PI3K inhibitor with an IC50 of 15.99±3.23 μM. Additionally, LX2343 stimulates autophagy, promoting Aβ clearance.
- $31
Size
QTY
Eslicarbazepine
Stedesa, Pazzul, Erelib, EC 810-248-9, BIA 2-194
T3285L104746-04-5
Eslicarbazepine (Stedesa) can be used for adjunctive therapy for adults with partial-onset seizures.
- $40
Size
QTY
Elenbecestat
E2609
T111751388651-30-6
Elenbecestat (E2609) is an effective oral bioutilization and CNS penetrating ACE-1 inhibitor for the treatment of Alzheimer's disease.
- $64
Size
QTY
LY2811376
T26391194044-20-6
LY2811376, an orally available non-peptidic β-secretase(BACE1) inhibitor (IC50: 239-249 nM), can decrease Aβ secretion (EC50: 300 nM). It has 10-fold selectivity towards BACE1 over BACE2, and more than 50-fold inhibition over other aspartic proteases including pepsin, cathepsin D, or renin.
- $48
Size
QTY
Cassiaside
TN147213709-03-0
Cassiaside is a naphthyl ketone glycoside that inhibits BACE1 (IC50= 4.45 μM; Ki=9.85 μM).Cassiaside exhibits significant hepatoprotective effects against galactosamine injury and has potential anti-Alzheimer's disease (AD) activity.
- $84
Size
QTY
AZD3839 free base
AZD3839
T67721227163-84-9
AZD3839 free base is a potent and selective BACE1 inhibitor with a Ki of 26.1 nM, demonstrating approximately 14-fold selectivity over BACE2. [Phase 1]
- $48
Size
QTY
Select Batch
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | BACE-IN-1 is amyloid precursor protein beta-secretase inhibitor |
| Molecular Weight | 1651.81 |
| Formula | C73H118N16O27 |
| Cas No. | 350228-37-4 |
Storage & Solubility Information
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO: Soluble |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy β-Secretase inhibitor-STA | purchase β-Secretase inhibitor-STA | β-Secretase inhibitor-STA cost | order β-Secretase inhibitor-STA | β-Secretase inhibitor-STA chemical structure | β-Secretase inhibitor-STA formula | β-Secretase inhibitor-STA molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.